Organon & Co. (OGN)

Number of records: 8
SEC FilingInsiderCompanyTrade DateTransactionSharesAvg. PriceTotal% HoldingsReturn
19-Aug-21 5:11 PM
View: 
Francisco Ma. Fatima
Director
Organon & Co. (OGN) 19-Aug-21Market Purchase 3,000$33.79$101,370.00100%
0 to 3.0K
(< 1%)
09-Aug-21 4:47 PM
View: 
Telman Deborah H
EVP GC & Corporate Secretary
Organon & Co. (OGN) 05-Aug-21Payment of Exercise 1,889$28.63$54,082.10(29%)
6.45K to 4.56K
(3%)
09-Aug-21 4:47 PM
View: 
Telman Deborah H
EVP GC & Corporate Secretary
Organon & Co. (OGN) 05-Aug-21Option Exercise 6,445$28.63$184,520.00100%
0 to 6.45K
3%
09-Aug-21 4:46 PM
View: 
Stahler Rachel A
Chief Information Officer
Organon & Co. (OGN) 05-Aug-21Payment of Exercise 4,416$28.63$126,430.00(34%)
12.89K to 8.47K
(3%)
09-Aug-21 4:46 PM
View: 
Stahler Rachel A
Chief Information Officer
Organon & Co. (OGN) 05-Aug-21Option Exercise 12,890$28.63$369,041.00100%
0 to 12.89K
3%
09-Aug-21 4:44 PM
View: 
Walsh Matthew M
Chief Financial Officer
Organon & Co. (OGN) 05-Aug-21Payment of Exercise 7,653$28.63$219,105.00(34%)
22.34K to 14.69K
(3%)
09-Aug-21 4:44 PM
View: 
Walsh Matthew M
Chief Financial Officer
Organon & Co. (OGN) 05-Aug-21Option Exercise 22,343$28.63$639,680.00100%
0 to 22.34K
3%
04-Jun-21 4:46 PM
View: 
Merck & Co., Inc.
10% Owner
Organon & Co. (OGN) 02-Jun-21Disposition (other) 253,516,000----(100%)
253.52M to 0